VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
ELVNEnliven Therapeutics, Inc.
$45.10$2.7B
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksELVNPrice History

ELVN logoEnliven Therapeutics, Inc. (ELVN) Stock Price History

Historical prices from 2020 to 2026

$45.10+0.24  (+0.53%)close Jun 18
Returns
1M
+13.8%
3M
+65.5%
YTD
+190.2%
1Y
+109.1%
3Y
+27.4%
5Y
+8.5%
ATH$250.84Jun 2020-82.0%
ATL$3.90Apr 2022pre-split
Avg Vol (50D)1.1M/ day
52-Week Range$14.79 — $48.50
LowCurrent: $45.10High

Loading 10-year price history...

ELVN Historical Performance

1 YearTotal Return
+109.1%
Price: +109.1%
3 YearsTotal Return
+107.0%
CAGR: +27.4%
Price: +107.0%
5 YearsTotal Return
+50.1%
CAGR: +8.5%
Price: +50.1%
YTD
+190.2%

ELVN Annual Returns

Year-by-year price performance · 2020–2026

Best+69.7%2022
Worst-90.6%2021
Up years4/7
2020+47.0%
2021-90.6%
2022+69.7%
2023-12.2%
2024+51.0%
2025-35.6%
2026+91.1%
2020 annual price return
+47.0%
2021 annual price return
-90.6%
2022 annual price return
+69.7%
2023 annual price return
-12.2%
2024 annual price return
+51.0%
2025 annual price return
-35.6%
2026 annual price return
+91.1%
LessMore
Alpha vs S&P 500
1Y+84.1%
3Y+7.7%
5Y-4.5%

Price returns only.

Download Historical Data

1,577 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

ELVN Stock Price Trajectory (2020–2026)

As of June 22, 2026, Enliven Therapeutics, Inc. (ELVN) trades at $45.10, representing a +109.1% return over the past year. The stock has delivered a +50.1% total return over five years (+8.5% CAGR), reflecting significant long-term value creation.

The stock reached its all-time high of $250.84 on June 9, 2020. From this peak, ELVN has corrected -82.0%, currently trading 60% above its 200-day moving average, indicating continued institutional support.

When compared to Healthcare sector peers KYMR (+94.7% 1Y), RVMD (+308.2% 1Y), and IMVT (+122.8% 1Y), ELVN has underperformed the peer group average. Compare ELVN vs KYMR →

ELVN Historical Price Data · from 2020

Rows 1–50 of 1,577
Date Open High Low Close Volume Change %
2026-06-1845.0145.7244.2245.102.16M+0.53%
2026-06-1742.7244.9542.2744.861.21M+5.43%
2026-06-1642.5144.0240.9542.553.42M+0.45%
2026-06-1546.6447.0041.4942.362.70M-8.17%
2026-06-1239.7747.3639.0046.136.14M+14.30%
2026-06-1145.5245.5240.2440.364.95M+9.08%
2026-06-1036.1537.4135.7137.001.26M+2.46%
2026-06-0934.4036.2034.2036.111.55M+7.37%
2026-06-0835.4535.7933.4533.63804K-3.11%
2026-06-0535.4935.8533.7234.711.07M-2.20%
2026-06-0436.0038.0135.4735.49998K-1.50%
2026-06-0335.4036.2334.9036.03680K+1.44%
2026-06-0237.3037.5335.4335.521.69M-5.31%
2026-06-0138.8239.6636.8537.51687K-5.21%
2026-05-2940.6540.9439.0239.57717K-2.66%
2026-05-2841.4841.4940.4440.65295K-1.84%
2026-05-2742.6742.9941.3141.41440K-2.63%
2026-05-2642.0442.5940.7542.53533K+2.38%
2026-05-2242.8043.0541.4341.54616K-1.68%
2026-05-2141.5942.8940.8042.25904K+0.93%
2026-05-2040.5642.3940.3041.86620K+4.21%
2026-05-1939.8240.2538.7640.17609K+1.36%
2026-05-1841.3441.7838.7839.63509K-4.14%
2026-05-1542.9542.9541.0741.34493K-4.04%
2026-05-1442.3043.5842.1243.08563K-1.10%
2026-05-1342.2445.1440.9243.561.05M+2.98%
2026-05-1240.6543.2840.0142.301.13M+6.85%
2026-05-1141.5142.0039.3439.59693K-2.85%
2026-05-0841.8442.9140.0240.75576K+1.14%
2026-05-0741.3341.3339.5440.29456K-2.21%
2026-05-0641.8442.3340.7641.20340K-0.91%
2026-05-0541.6942.9940.7241.58393K-0.07%
2026-05-0441.7142.1641.1641.61341K-0.22%
2026-05-0141.2643.5740.0641.70448K+1.14%
2026-04-3042.3543.4340.6941.23807K-2.76%
2026-04-2942.7243.8442.0042.40387K-1.35%
2026-04-2844.8445.3142.7742.98612K-4.28%
2026-04-2744.5046.8544.3544.90601K+1.47%
2026-04-2444.0044.5343.2644.25615K+0.82%
2026-04-2344.5245.0243.2643.89410K-1.24%
2026-04-2246.4446.9344.1444.44731K-3.16%
2026-04-2146.6346.6344.8845.89561K-1.12%
2026-04-2047.7448.1546.4046.41484K-3.53%
2026-04-1745.9548.5045.6448.111.36M+6.11%
2026-04-1643.8445.8042.6445.341.48M+3.16%
2026-04-1544.5844.7242.6243.95863K-2.01%
2026-04-1443.9345.3543.8444.85721K+2.33%
2026-04-1345.4145.6142.9443.831.12M-3.29%
2026-04-1045.6646.3044.6545.321.09M-0.59%
2026-04-0942.9346.2342.8845.592.26M+6.20%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

ELVN — Frequently Asked Questions

Quick answers to the most common questions about buying ELVN stock.

How has ELVN stock performed recently?

ELVN returned +109.1% over the past year, beating its 5-year annualized CAGR of +8.5%. The stock trades above its 200-day moving average, confirming the uptrend.

What is ELVN's all-time high price?

Enliven Therapeutics, Inc. reached $250.84 on 2020-06-09. The 52-week high is $48.50. Current 1-year return of +109.1% places the stock closer to historical peaks.

Where can I download ELVN historical price data?

This page provides ELVN daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2020-2026, downloadable in CSV format.

395 data points · sampled from 1,577